Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 78

1.

The Use of Random Forests to Classify Amyloid Brain PET.

Zukotynski K, Gaudet V, Kuo PH, Adamo S, Goubran M, Scott C, Bocti C, Borrie M, Chertkow H, Frayne R, Hsiung R, Laforce R Jr, Noseworthy MD, Prato FS, Sahlas DJ, Smith EE, Sossi V, Thiel A, Soucy JP, Tardif JC, Black SE.

Clin Nucl Med. 2019 Jul 24. doi: 10.1097/RLU.0000000000002747. [Epub ahead of print]

PMID:
31348088
2.

Are Cognitive Subtypes Associated with Dual-Task Gait Performance in a Clinical Setting?

Cullen S, Borrie M, Carroll S, Sarquis-Adamson Y, Pieruccini-Faria F, McKay S, Montero-Odasso M.

J Alzheimers Dis. 2019 Jul 18. doi: 10.3233/JAD-181196. [Epub ahead of print]

PMID:
31322559
3.

The Comprehensive Assessment of Neurodegeneration and Dementia: Canadian Cohort Study.

Chertkow H, Borrie M, Whitehead V, Black SE, Feldman HH, Gauthier S, Hogan DB, Masellis M, McGilton K, Rockwood K, Tierney MC, Andrew M, Hsiung GR, Camicioli R, Smith EE, Fogarty J, Lindsay J, Best S, Evans A, Das S, Mohaddes Z, Pilon R, Poirier J, Phillips NA, MacNamara E, Dixon RA, Duchesne S, MacKenzie I, Rylett RJ.

Can J Neurol Sci. 2019 Jul 16:1-13. doi: 10.1017/cjn.2019.27. [Epub ahead of print]

PMID:
31309917
4.

Ambroxol as a novel disease-modifying treatment for Parkinson's disease dementia: protocol for a single-centre, randomized, double-blind, placebo-controlled trial.

Silveira CRA, MacKinley J, Coleman K, Li Z, Finger E, Bartha R, Morrow SA, Wells J, Borrie M, Tirona RG, Rupar CA, Zou G, Hegele RA, Mahuran D, MacDonald P, Jenkins ME, Jog M, Pasternak SH.

BMC Neurol. 2019 Feb 9;19(1):20. doi: 10.1186/s12883-019-1252-3.

5.

Donepezil for gait and falls in mild cognitive impairment: a randomized controlled trial.

Montero-Odasso M, Speechley M, Chertkow H, Sarquis-Adamson Y, Wells J, Borrie M, Vanderhaeghe L, Zou GY, Fraser S, Bherer L, Muir-Hunter SW.

Eur J Neurol. 2019 Apr;26(4):651-659. doi: 10.1111/ene.13872. Epub 2018 Dec 26.

PMID:
30565793
6.

Correction to: The Toronto cognitive assessment (TorCA): normative data and validation to detect amnestic mild cognitive impairment.

Freedman M, Leach L, Carmela Tartaglia M, Stokes KA, Goldberg Y, Spring R, Nourhaghighi N, Gee T, Strother SC, Alhaj MO, Borrie M, Darvesh S, Fernandez A, Fischer CE, Fogarty J, Greenberg BD, Gyenes M, Herrmann N, Keren R, Kirstein J, Kumar S, Lam B, Lena S, McAndrews MP, Naglie G, Partridge R, Rajji TK, Reichmann W, Uri Wolf M, Verhoeff NPLG, Waserman JL, Black SE, Tang-Wai DF.

Alzheimers Res Ther. 2018 Dec 7;10(1):120. doi: 10.1186/s13195-018-0446-z.

7.

The Toronto Cognitive Assessment (TorCA): normative data and validation to detect amnestic mild cognitive impairment.

Freedman M, Leach L, Carmela Tartaglia M, Stokes KA, Goldberg Y, Spring R, Nourhaghighi N, Gee T, Strother SC, Alhaj MO, Borrie M, Darvesh S, Fernandez A, Fischer CE, Fogarty J, Greenberg BD, Gyenes M, Herrmann N, Keren R, Kirstein J, Kumar S, Lam B, Lena S, McAndrews MP, Naglie G, Partridge R, Rajji TK, Reichmann W, Uri Wolf M, Verhoeff NPLG, Waserman JL, Black SE, Tang-Wai DF.

Alzheimers Res Ther. 2018 Jul 18;10(1):65. doi: 10.1186/s13195-018-0382-y. Erratum in: Alzheimers Res Ther. 2018 Dec 7;10(1):120.

8.

Motor and Cognitive Trajectories Before Dementia: Results from Gait and Brain Study.

Montero-Odasso M, Speechley M, Muir-Hunter SW, Sarquis-Adamson Y, Sposato LA, Hachinski V, Borrie M, Wells J, Black A, Sejdić E, Bherer L, Chertkow H; Canadian Gait and Cognition Network.

J Am Geriatr Soc. 2018 Sep;66(9):1676-1683. doi: 10.1111/jgs.15341. Epub 2018 Apr 2.

PMID:
29608780
9.

Trial of Solanezumab for Mild Dementia Due to Alzheimer's Disease.

Honig LS, Vellas B, Woodward M, Boada M, Bullock R, Borrie M, Hager K, Andreasen N, Scarpini E, Liu-Seifert H, Case M, Dean RA, Hake A, Sundell K, Poole Hoffmann V, Carlson C, Khanna R, Mintun M, DeMattos R, Selzler KJ, Siemers E.

N Engl J Med. 2018 Jan 25;378(4):321-330. doi: 10.1056/NEJMoa1705971.

10.

Spontaneous low frequency BOLD signal variations from resting-state fMRI are decreased in Alzheimer disease.

Kazemifar S, Manning KY, Rajakumar N, Gómez FA, Soddu A, Borrie MJ, Menon RS, Bartha R; Alzheimer’s Disease Neuroimaging Initiative.

PLoS One. 2017 Jun 5;12(6):e0178529. doi: 10.1371/journal.pone.0178529. eCollection 2017.

11.

Association of Dual-Task Gait With Incident Dementia in Mild Cognitive Impairment: Results From the Gait and Brain Study.

Montero-Odasso MM, Sarquis-Adamson Y, Speechley M, Borrie MJ, Hachinski VC, Wells J, Riccio PM, Schapira M, Sejdic E, Camicioli RM, Bartha R, McIlroy WE, Muir-Hunter S.

JAMA Neurol. 2017 Jul 1;74(7):857-865. doi: 10.1001/jamaneurol.2017.0643. Erratum in: JAMA Neurol. 2017 Nov 1;74(11):1381.

12.

Binding, sliding, and function of cohesin during transcriptional activation.

Borrie MS, Campor JS, Joshi H, Gartenberg MR.

Proc Natl Acad Sci U S A. 2017 Feb 14;114(7):E1062-E1071. doi: 10.1073/pnas.1617309114. Epub 2017 Jan 30.

13.

Primary Care Collaborative Memory Clinics: Building Capacity for Optimized Dementia Care.

Lee L, Hillier LM, Molnar F, Borrie MJ.

Healthc Q. 2017;19(4):55-62.

PMID:
28130953
14.

Subjective rating of executive functions in mild Alzheimer's disease.

Fogarty J, Almklov E, Borrie M, Wells J, Roth RM.

Aging Ment Health. 2017 Nov;21(11):1184-1191. doi: 10.1080/13607863.2016.1207750. Epub 2016 Jul 25.

PMID:
27454406
15.

Disentangling Cognitive-Frailty: Results From the Gait and Brain Study.

Montero-Odasso MM, Barnes B, Speechley M, Muir Hunter SW, Doherty TJ, Duque G, Gopaul K, Sposato LA, Casas-Herrero A, Borrie MJ, Camicioli R, Wells JL.

J Gerontol A Biol Sci Med Sci. 2016 Nov;71(11):1476-1482. Epub 2016 Mar 16.

PMID:
26984391
16.

A hybrid manifold learning algorithm for the diagnosis and prognostication of Alzheimer's disease.

Dai P, Gwadry-Sridhar F, Bauer M, Borrie M.

AMIA Annu Symp Proc. 2015 Nov 5;2015:475-83. eCollection 2015.

17.

Oxytocin for frontotemporal dementia: a randomized dose-finding study of safety and tolerability.

Finger EC, MacKinley J, Blair M, Oliver LD, Jesso S, Tartaglia MC, Borrie M, Wells J, Dziobek I, Pasternak S, Mitchell DG, Rankin K, Kertesz A, Boxer A.

Neurology. 2015 Jan 13;84(2):174-81. doi: 10.1212/WNL.0000000000001133. Epub 2014 Dec 10.

18.

Reduced N-acetylaspartate to creatine ratio in the posterior cingulate correlates with cognition in Alzheimer's disease following four months of rivastigmine treatment.

Penner J, Wells JL, Borrie MJ, Woolmore-Goodwin SM, Bartha R.

Dement Geriatr Cogn Disord. 2015;39(1-2):68-80. doi: 10.1159/000367685. Epub 2014 Oct 24.

PMID:
25358336
19.

Primary Care-Based Memory Clinics: Expanding Capacity for Dementia Care.

Lee L, Hillier LM, Heckman G, Gagnon M, Borrie MJ, Stolee P, Harvey D.

Can J Aging. 2014 Sep;33(3):307-19. doi: 10.1017/S0714980814000233. Epub 2014 Aug 11.

PMID:
25111053
20.

Donepezil improves gait performance in older adults with mild Alzheimer's disease: a phase II clinical trial.

Montero-Odasso M, Muir-Hunter SW, Oteng-Amoako A, Gopaul K, Islam A, Borrie M, Wells J, Speechley M.

J Alzheimers Dis. 2015;43(1):193-9. doi: 10.3233/JAD-140759.

PMID:
25079803
21.

Role of emerging neuroimaging modalities in patients with cognitive impairment: a review from the Canadian Consensus Conference on the Diagnosis and Treatment of Dementia 2012.

Burhan AM, Bartha R, Bocti C, Borrie M, Laforce R, Rosa-Neto P, Soucy JP.

Alzheimers Res Ther. 2013 Jul 8;5(Suppl 1):S4. doi: 10.1186/alzrt200. Epub 2013 Jul 8.

22.

Clinical applications of neuroimaging in patients with Alzheimer's disease: a review from the Fourth Canadian Consensus Conference on the Diagnosis and Treatment of Dementia 2012.

Soucy JP, Bartha R, Bocti C, Borrie M, Burhan AM, Laforce R, Rosa-Neto P.

Alzheimers Res Ther. 2013 Jul 8;5(Suppl 1):S3. doi: 10.1186/alzrt199. Epub 2013 Jul 8.

23.

Automated algorithm to measure changes in medial temporal lobe volume in Alzheimer disease.

Kazemifar S, Drozd JJ, Rajakumar N, Borrie MJ, Bartha R; Alzheimer's Disease Neuroimaging Initiative.

J Neurosci Methods. 2014 Apr 30;227:35-46. doi: 10.1016/j.jneumeth.2014.01.033. Epub 2014 Feb 8.

PMID:
24518149
24.

Correcting the MoCA for education: effect on sensitivity.

Gagnon G, Hansen KT, Woolmore-Goodwin S, Gutmanis I, Wells J, Borrie M, Fogarty J.

Can J Neurol Sci. 2013 Sep;40(5):678-83.

PMID:
23968941
25.

Differences in rate of functional decline across three dementia types.

Gill DP, Hubbard RA, Koepsell TD, Borrie MJ, Petrella RJ, Knopman DS, Kukull WA.

Alzheimers Dement. 2013 Oct;9(5 Suppl):S63-71. doi: 10.1016/j.jalz.2012.10.010. Epub 2013 May 2.

26.

Motor cortex and gait in mild cognitive impairment: a magnetic resonance spectroscopy and volumetric imaging study.

Annweiler C, Beauchet O, Bartha R, Wells JL, Borrie MJ, Hachinski V, Montero-Odasso M.

Brain. 2013 Mar;136(Pt 3):859-71. doi: 10.1093/brain/aws373.

PMID:
23436505
27.

Safety and pharmacology of a single intravenous dose of ponezumab in subjects with mild-to-moderate Alzheimer disease: a phase I, randomized, placebo-controlled, double-blind, dose-escalation study.

Landen JW, Zhao Q, Cohen S, Borrie M, Woodward M, Billing CB Jr, Bales K, Alvey C, McCush F, Yang J, Kupiec JW, Bednar MM.

Clin Neuropharmacol. 2013 Jan-Feb;36(1):14-23. doi: 10.1097/WNF.0b013e31827db49b.

PMID:
23334070
28.

Specialist physicians in geriatrics-report of the canadian geriatrics society physician resource work group.

Hogan DB, Borrie M, Basran JF, Chung AM, Jarrett PG, Morais JA, Peters E, Rockwood KJ, St John PD, Sclater AL, Stultz T, Woolmore-Goodwin S.

Can Geriatr J. 2012 Sep;15(3):68-79. doi: 10.5770/cgj.15.41. Epub 2012 Sep 20.

29.

A novel MRI-compatible brain ventricle phantom for validation of segmentation and volumetry methods.

Khan AF, Drozd JJ, Moreland RK, Ta RM, Borrie MJ, Bartha R; Alzheimer's Disease Neuroimaging Initiative.

J Magn Reson Imaging. 2012 Aug;36(2):476-82. doi: 10.1002/jmri.23612. Epub 2012 Mar 7.

PMID:
22396226
30.

Association of common genetic variants in GPCPD1 with scaling of visual cortical surface area in humans.

Bakken TE, Roddey JC, Djurovic S, Akshoomoff N, Amaral DG, Bloss CS, Casey BJ, Chang L, Ernst TM, Gruen JR, Jernigan TL, Kaufmann WE, Kenet T, Kennedy DN, Kuperman JM, Murray SS, Sowell ER, Rimol LM, Mattingsdal M, Melle I, Agartz I, Andreassen OA, Schork NJ, Dale AM; Alzheimer's Disease Neuroimaging Initiative; Pediatric Imaging, Neurocognition, and Genetics Study, Weiner M, Aisen P, Petersen R, Jack CR Jr, Jagust W, Trojanowki JQ, Toga AW, Beckett L, Green RC, Saykin AJ, Morris J, Liu E, Montine T, Gamst A, Thomas RG, Donohue M, Walter S, Gessert D, Sather T, Harvey D, Kornak J, Dale A, Bernstein M, Felmlee J, Fox N, Thompson P, Schuff N, Alexander G, DeCarli C, Bandy D, Koeppe RA, Foster N, Reiman EM, Chen K, Mathis C, Cairns NJ, Taylor-Reinwald L, Trojanowki JQ, Shaw L, Lee VM, Korecka M, Crawford K, Neu S, Foroud TM, Potkin S, Shen L, Kachaturian Z, Frank R, Snyder PJ, Molchan S, Kaye J, Quinn J, Lind B, Dolen S, Schneider LS, Pawluczyk S, Spann BM, Brewer J, Vanderswag H, Heidebrink JL, Lord JL, Johnson K, Doody RS, Villanueva-Meyer J, Chowdhury M, Stern Y, Honig LS, Bell KL, Morris JC, Ances B, Carroll M, Leon S, Mintun MA, Schneider S, Marson D, Griffith R, Clark D, Grossman H, Mitsis E, Romirowsky A, deToledo-Morrell L, Shah RC, Duara R, Varon D, Roberts P, Albert M, Onyike C, Kielb S, Rusinek H, de Leon MJ, Glodzik L, De Santi S, Doraiswamy PM, Petrella JR, Coleman RE, Arnold SE, Karlawish JH, Wolk D, Smith CD, Jicha G, Hardy P, Lopez OL, Oakley M, Simpson DM, Porsteinsson AP, Goldstein BS, Martin K, Makino KM, Ismail MS, Brand C, Mulnard RA, Thai G, Mc-Adams-Ortiz C, Womack K, Mathews D, Quiceno M, Diaz-Arrastia R, King R, Weiner M, Martin-Cook K, DeVous M, Levey AI, Lah JJ, Cellar JS, Burns JM, Anderson HS, Swerdlow RH, Apostolova L, Lu PH, Bartzokis G, Silverman DH, Graff-Radford NR, Parfitt F, Johnson H, Farlow MR, Hake AM, Matthews BR, Herring S, van Dyck CH, Carson RE, MacAvoy MG, Chertkow H, Bergman H, Hosein C, Black S, Stefanovic B, Caldwell C, Ging-Yuek, Hsiung R, Feldman H, Mudge B, Assaly M, Kertesz A, Rogers J, Trost D, Bernick C, Munic D, Kerwin D, Mesulam MM, Lipowski K, Wu CK, Johnson N, Sadowsky C, Martinez W, Villena T, Turner RS, Johnson K, Reynolds B, Sperling RA, Johnson KA, Marshall G, Frey M, Yesavage J, Taylor JL, Lane B, Rosen A, Tinklenberg J, Sabbagh M, Belden C, Jacobson S, Kowall N, Killiany R, Budson AE, Norbash A, Johnson PL, Obisesan TO, Wolday S, Bwayo SK, Lerner A, Hudson L, Ogrocki P, Fletcher E, Carmichael O, Olichney J, Kittur S, Borrie M, Lee TY, Bartha R, Johnson S, Asthana S, Carlsson CM, Potkin SG, Preda A, Nguyen D, Tariot P, Fleisher A, Reeder S, Bates V, Capote H, Rainka M, Scharre DW, Kataki M, Zimmerman EA, Celmins D, Brown AD, Pearlson GD, Blank K, Anderson K, Santulli RB, Schwartz ES, Sink KM, Williamson JD, Garg P, Watkins F, Ott BR, Querfurth H, Tremont G, Salloway S, Malloy P, Correia S, Rosen HJ, Miller BL, Mintzer J, Longmire CF, Spicer K, Finger E, Rachinsky I, Drost D, Jernigan T, McCabe C, Grant E, Ernst T, Kuperman J, Chung Y, Murray S, Bloss C, Darst B, Pritchett L, Saito A, Amaral D, DiNino M, Eyngorina B, Sowell E, Houston S, Soderberg L, Kaufmann W, van Zijl P, Rizzo-Busack H, Javid M, Mehta N, Ruberry E, Powers A, Rosen B, Gebhard N, Manigan H, Frazier J, Kennedy D, Yakutis L, Hill M, Gruen J, Bosson-Heenan J, Carlson H.

Proc Natl Acad Sci U S A. 2012 Mar 6;109(10):3985-90. doi: 10.1073/pnas.1105829109. Epub 2012 Feb 16.

31.

Predictors of family caregiver ratings of patient quality of life in Alzheimer disease: cross-sectional results from the Canadian Alzheimer's Disease Quality of Life Study.

Naglie G, Hogan DB, Krahn M, Black SE, Beattie BL, Patterson C, Macknight C, Freedman M, Borrie M, Byszewski A, Bergman H, Streiner D, Irvine J, Ritvo P, Comrie J, Kowgier M, Tomlinson G.

Am J Geriatr Psychiatry. 2011 Oct;19(10):891-901. doi: 10.1097/JGP.0b013e3182006a7f.

32.

Predictors of patient self-ratings of quality of life in Alzheimer disease: cross-sectional results from the Canadian Alzheimer's Disease Quality of Life Study.

Naglie G, Hogan DB, Krahn M, Beattie BL, Black SE, Macknight C, Freedman M, Patterson C, Borrie M, Bergman H, Byszewski A, Streiner D, Irvine J, Ritvo P, Comrie J, Kowgier M, Tomlinson G.

Am J Geriatr Psychiatry. 2011 Oct;19(10):881-90. doi: 10.1097/JGP.0b013e3182006a67.

33.

Gait assessment in mild cognitive impairment and Alzheimer's disease: the effect of dual-task challenges across the cognitive spectrum.

Muir SW, Speechley M, Wells J, Borrie M, Gopaul K, Montero-Odasso M.

Gait Posture. 2012 Jan;35(1):96-100. doi: 10.1016/j.gaitpost.2011.08.014. Epub 2011 Sep 22.

PMID:
21940172
34.

Genetic variation in GOLM1 and prefrontal cortical volume in Alzheimer's disease.

Inkster B, Rao AW, Ridler K, Filippini N, Whitcher B, Nichols TE, Wetten S, Gibson RA, Borrie M, Kertesz A, Guzman DA, Loy-English I, Williams J, Saemann PG, Auer DP, Holsboer F, Tozzi F, Muglia P, Merlo-Pich E, Matthews PM.

Neurobiol Aging. 2012 Mar;33(3):457-65. doi: 10.1016/j.neurobiolaging.2010.04.018. Epub 2010 Jun 8.

PMID:
20570408
35.
36.

An exploration of cognitive subgroups in Alzheimer's disease.

Davidson JE, Irizarry MC, Bray BC, Wetten S, Galwey N, Gibson R, Borrie M, Delisle R, Feldman HH, Hsiung GY, Fornazzari L, Gauthier S, Guzman D, Loy-English I, Keren R, Kertesz A, George-Hyslop PS, Wherrett J, Monsch AU.

J Int Neuropsychol Soc. 2010 Mar;16(2):233-43. doi: 10.1017/S1355617709991160. Epub 2009 Dec 4.

37.

Increased glutamate in the hippocampus after galantamine treatment for Alzheimer disease.

Penner J, Rupsingh R, Smith M, Wells JL, Borrie MJ, Bartha R.

Prog Neuropsychopharmacol Biol Psychiatry. 2010 Feb 1;34(1):104-10. doi: 10.1016/j.pnpbp.2009.10.007. Epub 2009 Oct 13.

PMID:
19833161
38.

Quantitative gait analysis under dual-task in older people with mild cognitive impairment: a reliability study.

Montero-Odasso M, Casas A, Hansen KT, Bilski P, Gutmanis I, Wells JL, Borrie MJ.

J Neuroeng Rehabil. 2009 Sep 21;6:35. doi: 10.1186/1743-0003-6-35.

39.

Can cognitive enhancers reduce the risk of falls in older people with mild cognitive impairment? A protocol for a randomised controlled double blind trial.

Montero-Odasso M, Wells JL, Borrie MJ, Speechley M.

BMC Neurol. 2009 Aug 12;9:42. doi: 10.1186/1471-2377-9-42.

40.

Reduced hippocampal glutamate in Alzheimer disease.

Rupsingh R, Borrie M, Smith M, Wells JL, Bartha R.

Neurobiol Aging. 2011 May;32(5):802-10. doi: 10.1016/j.neurobiolaging.2009.05.002. Epub 2009 Jun 6.

PMID:
19501936
41.

Can cognitive enhancers reduce the risk of falls in people with dementia? An open-label study with controls.

Montero-Odasso M, Wells J, Borrie M.

J Am Geriatr Soc. 2009 Feb;57(2):359-60. doi: 10.1111/j.1532-5415.2009.02085.x. No abstract available.

42.

Anatomically-distinct genetic associations of APOE epsilon4 allele load with regional cortical atrophy in Alzheimer's disease.

Filippini N, Rao A, Wetten S, Gibson RA, Borrie M, Guzman D, Kertesz A, Loy-English I, Williams J, Nichols T, Whitcher B, Matthews PM.

Neuroimage. 2009 Feb 1;44(3):724-8. doi: 10.1016/j.neuroimage.2008.10.003. Epub 2008 Nov 1.

PMID:
19013250
43.

Ventricular enlargement as a possible measure of Alzheimer's disease progression validated using the Alzheimer's disease neuroimaging initiative database.

Nestor SM, Rupsingh R, Borrie M, Smith M, Accomazzi V, Wells JL, Fogarty J, Bartha R; Alzheimer's Disease Neuroimaging Initiative.

Brain. 2008 Sep;131(Pt 9):2443-54. doi: 10.1093/brain/awn146. Epub 2008 Jul 11.

44.

Diagnosis and treatment of dementia: 2. Diagnosis.

Feldman HH, Jacova C, Robillard A, Garcia A, Chow T, Borrie M, Schipper HM, Blair M, Kertesz A, Chertkow H.

CMAJ. 2008 Mar 25;178(7):825-36. doi: 10.1503/cmaj.070798. Review.

45.

High field (1)H MRS of the hippocampus after donepezil treatment in Alzheimer disease.

Bartha R, Smith M, Rupsingh R, Rylett J, Wells JL, Borrie MJ.

Prog Neuropsychopharmacol Biol Psychiatry. 2008 Apr 1;32(3):786-93. doi: 10.1016/j.pnpbp.2007.12.011. Epub 2007 Dec 23.

PMID:
18252268
46.

Frailty is associated with postoperative complications in older adults with medical problems.

Dasgupta M, Rolfson DB, Stolee P, Borrie MJ, Speechley M.

Arch Gerontol Geriatr. 2009 Jan-Feb;48(1):78-83. Epub 2008 Feb 20.

PMID:
18068828
47.

Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease.

Li H, Wetten S, Li L, St Jean PL, Upmanyu R, Surh L, Hosford D, Barnes MR, Briley JD, Borrie M, Coletta N, Delisle R, Dhalla D, Ehm MG, Feldman HH, Fornazzari L, Gauthier S, Goodgame N, Guzman D, Hammond S, Hollingworth P, Hsiung GY, Johnson J, Kelly DD, Keren R, Kertesz A, King KS, Lovestone S, Loy-English I, Matthews PM, Owen MJ, Plumpton M, Pryse-Phillips W, Prinjha RK, Richardson JC, Saunders A, Slater AJ, St George-Hyslop PH, Stinnett SW, Swartz JE, Taylor RL, Wherrett J, Williams J, Yarnall DP, Gibson RA, Irizarry MC, Middleton LT, Roses AD.

Arch Neurol. 2008 Jan;65(1):45-53. Epub 2007 Nov 12.

PMID:
17998437
48.

Functional neuroimaging in the diagnosis of dementia.

Borrie M.

Alzheimers Dement. 2007 Oct;3(4):336-40. doi: 10.1016/j.jalz.2007.07.004. Epub 2007 Sep 17. No abstract available.

PMID:
19595955
49.

Examining the nurse practitioner role in long-term care: evaluation of a pilot project in Canada.

Stolee P, Hillier LM, Esbaugh J, Griffiths N, Borrie MJ.

J Gerontol Nurs. 2006 Oct;32(10):28-36.

PMID:
17048754
50.

Treatment effect size of memantine therapy in Alzheimer disease and vascular dementia.

Smith M, Wells J, Borrie M.

Alzheimer Dis Assoc Disord. 2006 Jul-Sep;20(3):133-7. Review.

PMID:
16917181

Supplemental Content

Loading ...
Support Center